Traws Pharma Ownership 2024 | Who Owns Traws Pharma Now?

Overview Forecast RevenueFinancials Chart Transcripts

Institutional Ownership

8.17%

Insider Ownership

0.78%

Retail Ownership

91.06%

Institutional Holders

25.00

Traws Pharma Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-164	-100.00%	-	Jun 30, 2024
FMR LLC	-	-	-	-1,000	-100.00%	-	Jun 30, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A	-	-	-	-166	-100.00%	-	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-37,987	-100.00%	-	Jun 30, 2024

Traws Pharma's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-164	-100.00%	-	Jun 30, 2024
FMR LLC	-	-	-	-1,000	-100.00%	-	Jun 30, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A	-	-	-	-166	-100.00%	-	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-37,987	-100.00%	-	Jun 30, 2024

The largest Traws Pharma shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of Traws Pharma (ONTX), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-164	-100.00%	-	Jun 30, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A	-	-	-	-166	-100.00%	-	Jun 30, 2024
FMR LLC	-	-	-	-1,000	-100.00%	-	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-37,987	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Traws Pharma's largest institutional buyer is WELLS FARGO & COMPANY/MN. The company purchased -0.16K stocks of ONTX, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TWO SIGMA INVESTMENTS, LP	-	-	-	-37,987	-100.00%	-	Jun 30, 2024
FMR LLC	-	-	-	-1,000	-100.00%	-	Jun 30, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A	-	-	-	-166	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-164	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Traws Pharma's biggest institutional seller is TWO SIGMA INVESTMENTS, LP. The company sold -37.99K shares of ONTX, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TWO SIGMA INVESTMENTS, LP	-	-	-	-37,987	-100.00%	-	Jun 30, 2024
FMR LLC	-	-	-	-1,000	-100.00%	-	Jun 30, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A	-	-	-	-166	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-164	-100.00%	-	Jun 30, 2024

Traws Pharma's largest sold out institutional shareholder by shares sold is TWO SIGMA INVESTMENTS, LP, sold -37.99K shares, valued at -, as of undefined.

Traws Pharma Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
Principal Exchange-Traded Funds	0.10%	1,258,392	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.02%	10,015,583	-	-	Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.01%	216,619	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	106,675	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	687,631	-321,970	-31.89%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	181,873	-769	-0.42%	Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND II	0.00%	8,811	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	101,696	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	14,441	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	7,111	-	-	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	36,517	-	-	Jan 31, 2024
KINETICS PORTFOLIOS TRUST	0.00%	160	-	-	Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II	0.00%	586	-	-	Mar 31, 2024
Dimensional ETF Trust	0.00%	17,151	-	-	Jan 31, 2024
Blackstone Alternative Investment Funds	0.00%	1,333	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	2,348	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	2,835	-	-	Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	5,412	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	1,857	-	-	Mar 31, 2024

Traws Pharma's largest mutual fund holder by % of total assets is "Principal Exchange-Traded Funds", owning 1.26M shares, compromising 0.10% of its total assets.

Traws Pharma Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 24	25	4.17%
31 Dec, 23	24	-7.69%
30 Sep, 23	26	13.04%
30 Jun, 23	23	-
31 Mar, 23	23	-11.54%
31 Dec, 22	26	36.84%
30 Sep, 22	19	-
30 Jun, 22	19	-13.64%
31 Mar, 22	22	-26.67%
31 Dec, 21	30	-11.76%
30 Sep, 21	34	88.89%
30 Jun, 21	18	-

As of 31 Mar 24, 25 institutions are holding Traws Pharma's shares, representing an increase of 4.17% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 24	1,713,913	2.75%
31 Dec, 23	1,668,027	-6.39%
30 Sep, 23	1,781,920	-4.00%
30 Jun, 23	1,856,157	30.15%
31 Mar, 23	1,426,208	-8.10%
31 Dec, 22	1,551,940	-8.64%
30 Sep, 22	1,698,718	-4.07%
30 Jun, 22	1,770,808	-5.90%
31 Mar, 22	1,881,865	-19.43%
31 Dec, 21	2,335,610	-9.92%
30 Sep, 21	2,592,742	67.36%
30 Jun, 21	1,549,242	-

Traws Pharma (ONTX) has 1.71M shares outstanding as of 31 Mar 24, up 2.75% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 24	8.17%	12.95%
31 Dec, 23	7.94%	11.01%
30 Sep, 23	8.49%	10.83%
30 Jun, 23	8.86%	19.13%
31 Mar, 23	6.80%	12.35%
31 Dec, 22	7.42%	11.25%
30 Sep, 22	8.12%	11.32%
30 Jun, 22	8.47%	10.45%
31 Mar, 22	9.00%	4.68%
31 Dec, 21	13.88%	5.27%
30 Sep, 21	16.23%	16.84%
30 Jun, 21	9.82%	-

As of 31 Mar 24, Traws Pharma is held by 8.17% institutional shareholders, representing a 12.95% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 24	8	-
31 Dec, 23	8	-11.11%
30 Sep, 23	9	-18.18%
30 Jun, 23	11	83.33%
31 Mar, 23	6	-45.45%
31 Dec, 22	11	175.00%
30 Sep, 22	4	-55.56%
30 Jun, 22	9	-
31 Mar, 22	9	-10.00%
31 Dec, 21	10	-54.55%
30 Sep, 21	22	22.22%
30 Jun, 21	18	-

8 institutional shareholders have increased their position in ONTX stock as of 31 Mar 24 compared to 8 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 24	6	20.00%
31 Dec, 23	5	-
30 Sep, 23	5	150.00%
30 Jun, 23	2	-71.43%
31 Mar, 23	7	-12.50%
31 Dec, 22	8	33.33%
30 Sep, 22	6	100.00%
30 Jun, 22	3	-57.14%
31 Mar, 22	7	-36.36%
31 Dec, 21	11	57.14%
30 Sep, 21	7	-
30 Jun, 21	-	-

6 institutional shareholders have reduced their position in ONTX stock as of 31 Mar 24 compared to 5 in the previous quarter (a 20.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 24	25	4.17%	1,713,913	2.75%	8.17%	12.95%	8	-	6	20.00%
31 Dec, 23	24	-7.69%	1,668,027	-6.39%	7.94%	11.01%	8	-11.11%	5	-
30 Sep, 23	26	13.04%	1,781,920	-4.00%	8.49%	10.83%	9	-18.18%	5	150.00%
30 Jun, 23	23	-	1,856,157	30.15%	8.86%	19.13%	11	83.33%	2	-71.43%
31 Mar, 23	23	-11.54%	1,426,208	-8.10%	6.80%	12.35%	6	-45.45%	7	-12.50%
31 Dec, 22	26	36.84%	1,551,940	-8.64%	7.42%	11.25%	11	175.00%	8	33.33%
30 Sep, 22	19	-	1,698,718	-4.07%	8.12%	11.32%	4	-55.56%	6	100.00%
30 Jun, 22	19	-13.64%	1,770,808	-5.90%	8.47%	10.45%	9	-	3	-57.14%
31 Mar, 22	22	-26.67%	1,881,865	-19.43%	9.00%	4.68%	9	-10.00%	7	-36.36%
31 Dec, 21	30	-11.76%	2,335,610	-9.92%	13.88%	5.27%	10	-54.55%	11	57.14%
30 Sep, 21	34	88.89%	2,592,742	67.36%	16.23%	16.84%	22	22.22%	7	-
30 Jun, 21	18	-	1,549,242	-	9.82%	-	18	-	-	-

Traws Pharma Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 15, 2024	Guerin Mark Patrick	officer	CFO AND COO	F-InKind	Sell	2,591	$0.90	$2.33K	35,976
Mar 15, 2024	Guerin Mark Patrick	officer	CFO AND COO	M-Exempt	Sell	8,666	-	-	17,334
Mar 15, 2024	Fruchtman Steven M	director, officer	PRESIDENT, CHIEF EXECUTIVE OFF	F-InKind	Sell	8,727	$0.90	$7.85K	74,792
Mar 15, 2024	Fruchtman Steven M	director, officer	PRESIDENT, CHIEF EXECUTIVE OFF	M-Exempt	Sell	23,111	-	-	46,222
Feb 09, 2024	Guerin Mark Patrick	officer	CFO AND COO	F-InKind	Sell	2,443	$0.67	$1.64K	29,901
Feb 09, 2024	Guerin Mark Patrick	officer	CFO AND COO	M-Exempt	Sell	6,900	-	-	6,900
Feb 09, 2024	Fruchtman Steven M	director, officer	PRESIDENT, CHIEF EXECUTIVE OFF	F-InKind	Sell	9,212	$0.67	$6.17K	60,408
Feb 09, 2024	Fruchtman Steven M	director, officer	PRESIDENT, CHIEF EXECUTIVE OFF	M-Exempt	Sell	21,320	-	-	21,320

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 15, 2024	Guerin Mark Patrick	officer	CFO AND COO	M-Exempt	Buy	8,666	-	-	38,567
Mar 15, 2024	Guerin Mark Patrick	officer	CFO AND COO	F-InKind	Sell	2,591	$0.90	$2.33K	35,976
Mar 15, 2024	Guerin Mark Patrick	officer	CFO AND COO	M-Exempt	Sell	8,666	-	-	17,334
Mar 15, 2024	Fruchtman Steven M	director, officer	PRESIDENT, CHIEF EXECUTIVE OFF	M-Exempt	Buy	23,111	-	-	83,519
Mar 15, 2024	Fruchtman Steven M	director, officer	PRESIDENT, CHIEF EXECUTIVE OFF	F-InKind	Sell	8,727	$0.90	$7.85K	74,792
Mar 15, 2024	Fruchtman Steven M	director, officer	PRESIDENT, CHIEF EXECUTIVE OFF	M-Exempt	Sell	23,111	-	-	46,222
Feb 09, 2024	Guerin Mark Patrick	officer	CFO AND COO	M-Exempt	Buy	6,900	-	-	32,344
Feb 09, 2024	Guerin Mark Patrick	officer	CFO AND COO	F-InKind	Sell	2,443	$0.67	$1.64K	29,901
Feb 09, 2024	Guerin Mark Patrick	officer	CFO AND COO	M-Exempt	Sell	6,900	-	-	6,900
Feb 09, 2024	Fruchtman Steven M	director, officer	PRESIDENT, CHIEF EXECUTIVE OFF	M-Exempt	Buy	21,320	-	-	69,620
Feb 09, 2024	Fruchtman Steven M	director, officer	PRESIDENT, CHIEF EXECUTIVE OFF	F-InKind	Sell	9,212	$0.67	$6.17K	60,408
Feb 09, 2024	Fruchtman Steven M	director, officer	PRESIDENT, CHIEF EXECUTIVE OFF	M-Exempt	Sell	21,320	-	-	21,320
Oct 27, 2023	Moyo Victor M	officer	CHIEF MEDICAL OFFICER	A-Award	Buy	125,000	$0.74	$92.50K	125,000
Oct 27, 2023	Moyo Victor M		-		Buy	-	-	-	-
Aug 14, 2023	Shoemaker Mary Teresa	director	-	A-Award	Buy	66,468	$1.02	$67.80K	66,468
Aug 14, 2023	STOVER JACK E	director	-	A-Award	Buy	66,468	$1.02	$67.80K	66,468
Aug 14, 2023	Atadja Peter	director	-	A-Award	Buy	66,468	$1.02	$67.80K	66,468
Aug 14, 2023	Clarke Trafford	director	-	A-Award	Buy	66,468	$1.02	$67.80K	66,468
Aug 14, 2023	MEHTA VIREN	director	-	A-Award	Buy	66,468	$1.02	$67.80K	66,468
Aug 14, 2023	GROOPMAN JEROME	director	-	A-Award	Buy	66,468	$1.02	$67.80K	66,468

The last insider sell of Traws Pharma's stock was made by Guerin Mark Patrick on Mar 15 2024, selling 2,591 shares at $0.90 per share (valued at $2.33K).

Traws Pharma Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	4	8	50.00%
Q4 2023	1	-	-
Q3 2023	9	4	225.00%
Q2 2023	1	2	50.00%
Q1 2023	9	6	150.00%
Q4 2022	2	-	-
Q3 2022	11	6	183.33%
Q2 2022	3	-	-
Q1 2022	12	-	-
Q4 2021	2	1	200.00%
Q3 2021	17	-	-
Q2 2021	1	-	-
Q1 2021	8	-	-
Q4 2020	7	-	-
Q3 2020	12	3	400.00%
Q2 2020	4	-	-
Q4 2019	17	-	-
Q3 2019	9	21	42.86%
Q2 2019	-	2	-
Q4 2018	2	1	200.00%

4 total buy trades, and 8 total sell trades (buy/sell ratio of 0.50%) were made by Traws Pharma's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	-	-
Q4 2023	-	-	-
Q3 2023	-	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	4	-	-
Q4 2021	1	-	-
Q3 2021	4	-	-
Q2 2021	-	-	-
Q1 2021	5	-	-
Q4 2020	7	-	-
Q3 2020	-	3	-
Q2 2020	4	-	-
Q4 2019	12	-	-
Q3 2019	3	17	17.65%
Q2 2019	-	2	-
Q4 2018	-	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Traws Pharma's stocks.

Traws Pharma Peer Ownership

Ticker	Company
GOVX	GeoVax Labs, Inc.
PULM	Pulmatrix, Inc.
ADIL	Adial Pharmaceuticals, Inc.
BPTH	Bio-Path Holdings, Inc.
AEZS	Aeterna Zentaris Inc.
TNXP	Tonix Pharmaceuticals Holding Corp.
VBIV	VBI Vaccines Inc.
DFFN	CervoMed Inc.
JAGX	Jaguar Health, Inc.
VXRT	Vaxart, Inc.
SONN	Sonnet BioTherapeutics Holdings, Inc.
MBRX	Moleculin Biotech, Inc.
CBIO	Gyre Therapeutics, Inc.
OCGN	Ocugen, Inc.
PALI	Palisade Bio, Inc.

ONTX Ownership FAQ

Who Owns Traws Pharma?

Traws Pharma is owned by institutional shareholders (8.17%), insiders (0.78%), and public (91.06%). The largest institutional shareholder of Traws Pharma is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is Principal Exchange-Traded Funds (0.10% of total shares).

Who are the major institutional shareholders of Traws Pharma?

Traws Pharma's major institutional shareholders are WELLS FARGO & COMPANY/MN, FMR LLC, OLD POINT TRUST & FINANCIAL SERVICES N A, and TWO SIGMA INVESTMENTS, LP. The top five shareholders own together 0% of the company's share outstanding.

How many Traws Pharma shareholders are there?

As of Mar 2024, there are 25 institutional shareholders of Traws Pharma.

What percentage of Traws Pharma is owned by WELLS FARGO & COMPANY/MN?

WELLS FARGO & COMPANY/MN owns 0 shares of Traws Pharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).

What percentage of Traws Pharma is owned by FMR LLC?

As of Jun 2024, FMR LLC holds 0 shares of Traws Pharma (ONTX), compromising 0% of the company, valued at $0.

What percentage of Traws Pharma is owned by OLD POINT TRUST & FINANCIAL SERVICES N A?

OLD POINT TRUST & FINANCIAL SERVICES N A is the third largest holder of Traws Pharma. The company owns 0 of the company's shares outstanding (worth $0).